Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 9214248)

Published in Ann Intern Med on July 01, 1997

Authors

T Maier-Dobersberger1, P Ferenci, C Polli, P Balać, H P Dienes, K Kaserer, C Datz, W Vogel, A Gangl

Author Affiliations

1: Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Vienna, Austria.

Articles by these authors

Calcium inward currents in internally perfused giant axons. J Physiol (1973) 5.02

Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15

[Effect of tetrodotoxin and tertaethylammonium chloride on the inside of the membrane of Ranvier's node in Xenopus laevis]. Pflugers Arch (1969) 3.88

Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59

Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52

Serum levels of cytokines in chronic liver diseases. Gastroenterology (1992) 3.47

Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res (2000) 2.83

Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet (1999) 2.68

Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell (1998) 2.64

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59

Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53

Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40

Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21

Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol (2001) 2.20

Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood (1994) 2.16

Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12

ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11

Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04

Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02

What's on doctors' ball point pens? Lancet (1998) 2.02

Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet (1993) 2.00

Potassium inactivation in single myelinated nerve fibres of Xenopus laevis. Pflugers Arch (1971) 1.98

Visualization of the conservation of synteny between humans and pigs by heterologous chromosomal painting. Genomics (1995) 1.94

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92

Evaluation of a virtual endoscopy simulator for training in gastrointestinal endoscopy. Endoscopy (2002) 1.91

Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy (2008) 1.91

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Aliment Pharmacol Ther (2011) 1.85

Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer (2001) 1.85

Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1990) 1.83

Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene (1995) 1.81

Inactivation of the asymmetrical displacement current in giant axons of Loligo forbesi. J Physiol (1977) 1.80

[The Geriatric Minimum Data Set (Gemidas) of the Federal Association of Clinical Geriatric Facilities e. V. as an instrument for quality assurance in inpatient geriatrics]. Z Gerontol Geriatr (1999) 1.80

Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology (1999) 1.79

Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol (1990) 1.78

[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer (1996) 1.76

Interactions of drugs with adrenergic neurons. Pharmacol Rev (1966) 1.76

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76

Calcium and lanthanum effects at the nodal membrane. Pflugers Arch (1974) 1.74

TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol (1999) 1.69

Echinococcus multilocularis revisited. AJR Am J Roentgenol (2001) 1.69

Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol (1995) 1.68

Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology (2001) 1.68

Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68

Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67

Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur J Gastroenterol Hepatol (1995) 1.64

Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62

Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60

Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53

Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy (1998) 1.53

Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab (2005) 1.51

Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology (2008) 1.51

Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol (2001) 1.50

Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. Br J Dermatol (1999) 1.50

Properties and functions of calcium-activated K+ channels in small neurones of rat dorsal root ganglion studied in a thin slice preparation. J Physiol (1998) 1.49

Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Int (2006) 1.47

Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol (1999) 1.46

A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution? Trends Genet (2001) 1.46

Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45

Further observations of true mosaic trisomy 17 ascertained in amniotic fluid cell cultures. Prenat Diagn (1998) 1.44

Visualization of intestinal splenosis by somatostatin receptor scintigraphy. Am J Gastroenterol (1998) 1.43

Inseparability criteria for continuous bipartite quantum states. Phys Rev Lett (2005) 1.43

Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Wien Klin Wochenschr (2000) 1.42

Serial duplication of 10 (q11 leads to q22) in a patient with minor congenital malformations. Clin Genet (1978) 1.42

p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol (2001) 1.42

Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology (1991) 1.41

[Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria]. Wien Klin Wochenschr (2000) 1.40

ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40

False-negative findings in chorionic villus sampling. An experimental approach and review of the literature. Prenat Diagn (1998) 1.39

[Geriatric treatment in hospitals?--medical, legal, and economic aspects]. Z Gerontol Geriatr (2007) 1.39

Bacille Calmette-Guérin--associated neonatal hepatitis. Eur J Pediatr (1991) 1.38

Failed spinal anesthesia with the Sprotte needle. Anesthesiology (1991) 1.38

[Personal experience with prevention and therapy of infection after 53 liver transplantations]. Langenbecks Arch Chir (1991) 1.38

Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol (1997) 1.37

Slow recovery of sodium current and 'gating current' from inactivation. J Physiol (1977) 1.37

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol (1999) 1.35

High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer (2005) 1.31

HLA antigens in inflammatory bowel disease. Gastroenterology (1982) 1.31

Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology (1992) 1.27

Single-channel recording in myelinated nerve fibers reveals one type of Na channel but different K channels. Proc Natl Acad Sci U S A (1989) 1.26

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology (1999) 1.25

The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest (2001) 1.25

Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr (1983) 1.25